Irene Richard is a Neurology physician affiliated with University of Rochester Medicine. OpenAlex indexes 95 publications with 7,847 citations (h-index 36); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
919 Westfall Rd
Bldg C, Suite 220
Rochester, NY 14618
Telephone
585-341-7500Registry record last updated 3 Jul 2023.
Clinical trials
- Buspirone in Parkinson's Disease
Sponsor: University of Rochester
- Study of Antidepressants in Parkinson's Disease
Sponsor: University of Rochester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Mood Stabilizer100%Carbamazepine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1998–2008 per NIH RePORTER. The latest:
- Study of Antidepressants in Parkinson's Disease (SAD PD)
University of Rochester
FY2008$844,655R01NS046487 - Study of Antidepressants in Parkinson's Disease (SAD PD)
University of Rochester
FY2007$615,485R01NS046487 - Study of Antidepressants in Parkinson's Disease (SAD PD)
University of Rochester
FY2005$1,087,557R01NS046487
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Postoperative Delirium and Parkinson Disease After Common United States Surgical Procedures
Journal of Surgical Research
2023 - Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Annals of Clinical and Translational Neurology
2020 - A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability
Parkinsonism & Related Disorders
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Beck, MD
University of Rochester Medicine
Benzi Kluger, MD
University of Rochester Medicine
Darren Tabechian, MD
University of Rochester Medicine
Ayesa Mian, MD
University of Rochester Medicine
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”